Current and historical daily PE Ratio for AS Latvijas Juras medicinas centrs (
ORSE:LJM1R
) from 1998 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. AS Latvijas Juras medicinas centrs stock (ORSE:LJM1R) PE ratio as of Jun 09 2024 is 30.63.
More Details
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) PE Ratio (TTM) Chart
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) PE Ratio (TTM) Historical Data
View and export this data going back to 1998. Start your Free Trial
Total 1291
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| AS Latvijas Juras medicinas centrs PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 30.6 | 2024-04-08 | 30.2 |
| 2024-06-07 | 30.6 | 2024-04-05 | 30.0 |
| 2024-06-06 | 30.6 | 2024-04-04 | 39.5 |
| 2024-06-05 | 30.6 | 2024-04-03 | 39.5 |
| 2024-06-04 | 30.6 | 2024-04-02 | 39.5 |
| 2024-06-03 | 30.0 | 2024-04-01 | 39.5 |
| 2024-05-31 | 30.0 | 2024-03-29 | 39.5 |
| 2024-05-30 | 31.6 | 2024-03-28 | 39.5 |
| 2024-05-29 | 31.6 | 2024-03-27 | At Loss |
| 2024-05-28 | 31.6 | 2024-03-26 | At Loss |
| 2024-05-27 | 31.6 | 2024-03-25 | At Loss |
| 2024-05-24 | 31.6 | 2024-03-22 | At Loss |
| 2024-05-23 | 31.6 | 2024-03-21 | At Loss |
| 2024-05-22 | 31.6 | 2024-03-20 | At Loss |
| 2024-05-21 | 28.1 | 2024-03-19 | At Loss |
| 2024-05-20 | 30.0 | 2024-03-18 | At Loss |
| 2024-05-17 | 30.0 | 2024-03-15 | At Loss |
| 2024-05-16 | 31.6 | 2024-03-14 | At Loss |
| 2024-05-15 | 31.6 | 2024-03-13 | At Loss |
| 2024-05-14 | 31.6 | 2024-03-12 | At Loss |
| 2024-05-13 | 31.6 | 2024-03-11 | At Loss |
| 2024-05-10 | 31.6 | 2024-03-08 | At Loss |
| 2024-05-09 | 31.6 | 2024-03-07 | At Loss |
| 2024-05-08 | 31.6 | 2024-03-06 | At Loss |
| 2024-05-07 | 31.6 | 2024-03-05 | At Loss |
| 2024-05-06 | 31.6 | 2024-03-04 | At Loss |
| 2024-05-03 | 31.6 | 2024-03-01 | At Loss |
| 2024-05-02 | 31.6 | 2024-02-29 | At Loss |
| 2024-05-01 | 31.6 | 2024-02-28 | At Loss |
| 2024-04-30 | 31.6 | 2024-02-27 | At Loss |
| 2024-04-29 | 31.6 | 2024-02-26 | At Loss |
| 2024-04-26 | 31.6 | 2024-02-23 | At Loss |
| 2024-04-25 | 31.6 | 2024-02-22 | At Loss |
| 2024-04-24 | 27.7 | 2024-02-21 | At Loss |
| 2024-04-23 | 27.7 | 2024-02-20 | At Loss |
| 2024-04-22 | 27.7 | 2024-02-19 | At Loss |
| 2024-04-19 | 27.7 | 2024-02-16 | At Loss |
| 2024-04-18 | 27.7 | 2024-02-15 | At Loss |
| 2024-04-17 | 30.0 | 2024-02-14 | At Loss |
| 2024-04-16 | 30.0 | 2024-02-13 | At Loss |
| 2024-04-15 | 30.0 | 2024-02-12 | At Loss |
| 2024-04-12 | 29.8 | 2024-02-09 | At Loss |
| 2024-04-11 | 35.6 | 2024-02-08 | At Loss |
| 2024-04-10 | 29.6 | 2024-02-07 | At Loss |
| 2024-04-09 | 29.6 | 2024-02-06 | At Loss |
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
AS Latvijas Juras medicinas centrs
ISIN : LV0000100741
Compare
Compare
Traded in other countries / regions
LJM1R.Latvia IPO Date
1998-05-11Description
AS Latvijas Juras medicinas centrs is engaged in the provision of healthcare services. It operates hospitals and diagnostic centers. The company offers diagnostics services, magnetic resonance imaging, radiological diagnostics services, and ambulance services. It is also engaged in General medical practice activities, Special medical practice activities, Residential nursing care activities, Retail sale of medical and orthopedic goods in specialized stores, and Other personal service activities.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers